Multiclass <scp>HCV</scp> resistance to direct‐acting antiviral failure in real‐life patients advocates for tailored second‐line therapiesVelia Chiara Di Maio, Francesca Ceccherini‐Silberstein, Piera Rossi et al.|Liver International|2017Cited by 90
Early HCV clearance kinetic: analysis and comparison in non responders patients versus naive patientsFrancesco Torre, A. Picciotto, Rachel S. Levy‐Drummer et al.|Journal of Hepatology|2002Cited by 1